Clinical Trials Directory

Trials / Unknown

UnknownNCT00356239

Implantable Cardioverter Defibrillators And Magnetic Resonance Imaging of the Heart at 1.5 Tesla

Evaluation of Safety and Feasibility Magnetic Resonance Imaging of the Heart at 1.5 Tesla In Patients With Implantable Cardioverter Defibrillators

Status
Unknown
Phase
Study type
Observational
Enrollment
25 (planned)
Sponsor
University Hospital, Bonn · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

To evaluate short-term and long-term effects by MR imaging on the technical and functional status of implantable cardioverter defibrillators.

Detailed description

The presence of an implantable cardioverter defibrillators (ICD) is currently considered an absolute contraindication to MR imaging, and most patients with PM are excluded from having MRI. As a result from studies such as MADIT I, MADIT II, SCDHeft etc. the number of patients with ICDs has been continuously growing over the past years, ans this development will continue. The aim of this study is to develop a strategy for safe performance of MR imaging at 1.5T, which included restriction of specific absorption rate (SAR) values to minimize the risk of lead heating, and ICD reprogramming to avoid interference from time varying gradient fields. The safety of this approach is then evaluated in a large group of ICD patients including assessment of potential myocardial thermal injury by measuring serum troponin I and pacing capture thresholds, and performing a follow-up 6 weeks after MR imaging to evaluate long-term effects.

Conditions

Timeline

Start date
2006-07-01
First posted
2006-07-25
Last updated
2007-04-11

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00356239. Inclusion in this directory is not an endorsement.